CURE Intelligence appoints Michael Feiten to the management board

Michael Feiten brings an exceptional combination of long-standing business experience, philosophical depth, and profound expertise in artificial intelligence and digital transformation, as well as their ethical implications. As a former lead fund manager, he understands the dynamics of complex markets and the responsibility that accompanies entrepreneurial decision-making with a strong focus on delivering tangible value for clients.

As editor of the book “Digitalisierung und Digitalität: Interdisziplinäre Einblicke in technische Möglichkeiten und gesellschaftliche Phänomene” (Frank & Timme Publishing), he has explored, together with authors from different disciplines, the technological opportunities and societal implications of digital transformation. The publication highlights how digital technologies are fundamentally changing companies, decision-making processes, and our understanding of responsibility.

“Artificial intelligence and data-driven systems are opening up entirely new opportunities for companies to make better and more informed decisions. The key is to combine technological innovation with a clear sense of responsibility and a tangible benefit for organizations and people,” explains Michael Feiten.

His work as a lecturer and coach shapes his leadership style, combining analytical precision with a humanistic perspective. At the core of his work lies the question of how companies can effectively and responsibly implement technological innovation – particularly in the areas of artificial intelligence, digital and media processes, and data-driven market, media, and marketing intelligence.

This perspective aligns closely with the positioning of CURE Intelligence as a provider of highly specialized, data- and AI-driven intelligence solutions.

“CURE Intelligence combines technological expertise, analytical depth, and a clear understanding of markets, media, and communication. I look forward to further strengthening these capabilities together with the team and actively shaping the development of data- and AI-driven intelligence solutions,” Feiten adds.

The strategic development of CURE Intelligence will be further defined in the coming months. A stronger focus on artificial intelligence, ethically reflected decision-making models, and high-quality intelligence services will form the foundation for the company’s next phase of growth.